Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Tumor necrosis factor-alpha 308G>A polymorphism cause coronary heart disease in type-2 diabetic patients of the northern region of Bangladesh

Md. Rezuan Al Mahmud,Md. Mahmudul Hasan,Dipa Roy,Md. Sk Shahid Ullah,Bristy Basak,Md. Abu Reza,Ariful Haque.




Abstract

Tumor necrosis factor-alpha (TNF-α) is a major cytokine for inflammatory response in human body. This is also well linked with obesity and causing different pathophysiological problems in type 2 diabetic mellitus (T2DM) patients because of its pro-inflammatory over expression. However, seemingly harmless nucleotide changes in the promoter region often cause oscillation in expression, results in complications like dyslipidemia and atherosclerosis that ultimately exploit to coronary heart disease (CHD). Therefore, this study was designed to evaluate association between TNF-α (-308G>A) polymorphism at promoter region and CHD in T2DM patients from the northern region (Rajshahi) of Bangladesh. The total number of participants was 96 T2DM patients. TNF-α polymorphism were detected using high resolution melting (HRM) curve analysis. A total of 32 participants were suffering from CHD and 8 polymorphism (3 homozygous and 5 heterozygous) were detected among them. From Fisher’s Exact test, we found significant (P < 0.05) relationship between TNF-α polymorphism and CHD in T2DM patients. According to Kendall’s Tau correlation matrix (r = 0.218), there is a good correlation between polymorphism and CHD. Therefore, the overall results suggest that TNF-α (-308G>A) polymorphism is responsible for inducing CHD in T2DM patients.

Key words: Tumor necrosis factor-alpha, Polymorphism, Cardiac disease, Type 2 diabetes mellitus, Bangladesh






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.